该NR4A2 / VGF通路通过促进神经元糖解促进炎症诱导的神经退行
Marcel S Woo1, Lukas C Bal1, Ingo Winschel1
1Institute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
The Journal of clinical investigation
|August 15, 2024
概括
一项关于多发性硬化症 (MS) 的研究发现,兴奋和抑制 (E/I平衡) 之间的不平衡驱动神经退行. 与NR4A2相关的VGF水平增加,促进神经元细胞死亡,为MS提供新的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 扰乱刺激抑制 (E/I) 平衡与多发性硬化症 (MS) 中的神经退行有关.
- 慢性过度兴奋可能导致MS中神经元损失.
- 了解将E/I不平衡与神经退行症联系在一起的机制至关重要.
研究的目的:
- 调查慢性过度兴奋如何导致MS中神经元损失.
- 确定参与MS炎症诱导的神经退行症的分子途径.
- 探索NR4A2和VGF在MS病变发生中的作用.
主要方法:
- 来自具有改变E / I平衡的小鼠的神经元的转录概况.
- 研究NR4A2在刺激毒性和神经元细胞死亡中的功能.
- 在小鼠模型和人类MS样本中测量VGF水平.
- 在MS的小鼠模型中,Vgf的遗传删除.
主要成果:
- 在神经元中观察到受损的E/I平衡和增加的NR4A2诱导.
- 通过VGF分泌,NR4A2促进了兴奋毒性和依赖于糖溶解的神经元细胞死亡.
- 在MS (pwMS) 患者的血清和脑活检中发现VGF水平升高.
- 在MS小鼠模型中,神经元特定的Vgf删除改善了神经退行.
结论:
- 由激发性活动驱动的持续代谢转变是炎症诱导的神经退行症的关键机制.
- NR4A2和VGF信号代表了MS的潜在治疗目标.
- 恢复E / I平衡可能是治疗MS的可行策略.
相关概念视频
Neurogenesis and Regeneration of Nervous Tissue
747
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
747
Enzyme-linked Receptors
77.7K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
77.7K


